× ×ª×× × ×ª×¨×פ×
××רש×
| ק×××¦× ×¤×¨×ק×××××ת (ATC4)
|
L01FX
Other monoclonal antibodies and antibody drug conjugates
|
| ×ר××× ×¤×¢×× (ATC5)
|
Â
|
| צ×רת ×ת×
|
ת××-×ר××× - I.V
|
| צ×רת ××× ××
|
×××§× ×××× ×ª ת×××¡× ×ר×××ת ××¢×ר××, POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION
××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר××
|
| ×ת××××
|
MYLOTARG is indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults and pediatric patients 1 month and older.MYLOTARG is indicated for the treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and in pediatric patients 2 years and olderâ¦â¦.
|
| × ×ª×× × ×ס×
|
ת×ר×× ××××× ×ס×
- 20/09/2006
|
×××××ת ×ס×
- תר××¤× ×××××ת ×ר×ש×× ×¢'× ×¨××¤× ××××× ×× ××××× ××רת
|
×ת×××× ×ס×
| ×ת×××× |
ת×ר×× ××××× |
ת××× ×§××× × |
Class Effect |
××¦× ×××× |
×ס×ס ×××××ת
|
| ×××× ××ק××× ×ס×× CD33 positive Acute Myeloid Leukemia (AML) ×× × ×©× ×ª××× ×××¢×× ××××¨× ×ר×ש×× × ×©× ×××××, ש××× × ×××××× ×ק×× ××פ×× ×××××ª×¨×¤× ×¦×××××קס×. |
30/01/2020 |
××××××××× |
|
Acute myeloid leukemia |
|
| ×××× ××ק××× ×ס×× CD33 positive Acute Myeloid Leukemia (AML), ×¤×¨× ×××××× ×©××××ª× ××©× ×ת ×תס××× ×ª ×××××××ספ×ס××ת, ש×××¢×××× ×××פ×× ×¢× ××××תרפ×× ××× ×× ×¡×××ת, ××§× ××פ×× ×¨×ש×× |
16/01/2019 |
××××××××× |
|
××ק××× ×ס×× AML, Acute myeloid leukemia |
|
| ×××× ××ק××× ×ס×× CD33 positive Acute Myeloid Leukemia (AML) ×× × 60 ×©× × ×××¢×× ××××¨× ×ר×ש×× × ×©× ×××××, ש××× × ×××××× ×ק×× ××פ×× ×××××ª×¨×¤× ×¦××××××§×¡× |
20/09/2006 |
××××××××× |
|
××ק××× ×ס×× AML, Acute Myeloid leukemia |
|
|
ש×××ש ×ס×
-
|
×ס×רת ××××× ×ס×
- ×. ×תר××¤× ×ª×× ×ª× ×××פ×× ××קר×× ××××:
- 1. ×××× ××ק××× ×ס×× CD33 positive Acute Myeloid Leukemia (AML) ×× × ×©× ×ª××× ×××¢×× ××××¨× ×ר×ש×× × ×©× ×××××, ש××× × ×××××× ×ק×× ××פ×× ×××××ª×¨×¤× ×¦×××××קס×.
- 2. ×××× ××ק××× ×ס×× CD33 positive Acute Myeloid Leukemia (AML), ×¤×¨× ×××××× ×©××××ª× ××©× ×ת ×תס××× ×ª ×××××××ספ×ס××ת, ש×××¢×××× ×××פ×× ×¢× ××××תרפ×× ××× ×× ×¡×××ת, ××§× ××פ×× ×¨×ש××.
- ×. ××ª× ×תר××¤× ×××¢×©× ××¤× ××¨×©× ×©× ××××× ××××××××××.
|
|
| ×ת××××ת × ××
|
Contraindications
|
| ש×××ש ×××ר××× ××× ×§×
|
Pregnancy and Lactation
|
| פר×ק×××× ××ק×
|
Pharmacodynamic Properties
|
| פר×ק×ק×× ××ק×
|
Pharmacokinetic Properties
|
| ×¢××× ×ר××¤× ××××ר×ת ××¢×××
|
Â
Â
|
| ××פ×ש ×××ר××
|
×××ר×× ×-PubMed
|
| ××××¢ ×רשת
|
RxList WebMD Drugs.com
|
| ×©× ×צר×
|
PFIZER INC., USA
|
| ×©× ××¢× ×ר×ש××
|
PFIZER PHARMACEUTICALS ISRAEL LTD
|
| ר×ש×××
|
ת×ר×× ××ש×: 10/06/2001. ר×ש××× ×ת×ר××: 30/06/2008
|
| ת×ר×× ×¢×××× ××ר××
|
05/03/2025
|
ת××× ×ª ×ר×××
ת×ר×× ×¢××××: 05/03/2025
PFIZER
××××××××¨× - Mylotarg
true
[[[ק×××ר××:Antineoplastic and immunomodulating agents - L]]
השינוי האחרון נעשה בֹ־5 במרץ 2025 ב־03:03
